United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 19, 2026 · Filed Aug 20, 2026

On Aug 19, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$526.96 for US$5.01M under a trading plan, leaving 324,443 shares. Filed Aug 20, 2026 (Form 4).

Sold
9,500 shares
Price
US$526.96 average (US$522.49 to US$535.22)
Value
US$5.01M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 19, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 19, 2026Common StockSale240US$522.49333,703Indirect
Aug 19, 2026Common StockSale1,264US$523.65332,439Indirect
Aug 19, 2026Common StockSale441US$524.51331,998Indirect
Aug 19, 2026Common StockSale895US$525.60331,103Indirect
Aug 19, 2026Common StockSale2,105US$526.76328,998Indirect
Aug 19, 2026Common StockSale2,135US$527.58326,863Indirect
Aug 19, 2026Common StockSale1,200US$528.59325,663Indirect
Aug 19, 2026Common StockSale659US$529.56325,004Indirect
Aug 19, 2026Common StockSale201US$531.01324,803Indirect
Aug 19, 2026Common StockSale80US$531.62324,723Indirect
Aug 19, 2026Common StockSale200US$532.63324,523Indirect
Aug 19, 2026Common StockSale80US$535.22324,443Indirect

Source

View original at SEC

Related